Petros Pharmaceuticals, Inc.
PTPI
$0.0849
-$0.007-7.62%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.73M | -7.06M | -8.94M | -8.16M | -12.70M |
| Total Depreciation and Amortization | 3.21M | 3.30M | 3.41M | 3.51M | 3.61M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.36M | -6.78M | -5.30M | -3.60M | 1.72M |
| Change in Net Operating Assets | 4.04M | 1.43M | 2.82M | 624.90K | 430.30K |
| Cash from Operations | -5.83M | -9.10M | -8.01M | -7.63M | -6.94M |
| Capital Expenditure | -19.10K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -19.10K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.14M | -1.12M | -1.11M | -1.46M | -1.27M |
| Issuance of Common Stock | 15.00M | 30.00M | 30.00M | 30.00M | 15.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -7.09M | -4.70M | -3.12M | -2.00M | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -15.00M | -15.00M | -15.00M | -15.00M | -- |
| Cash from Financing | -8.23M | 9.18M | 10.77M | 11.54M | 13.73M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.08M | 75.20K | 2.76M | 3.91M | 6.79M |
